Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan

Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan

<i>Background and Objectives</i>: Direct-acting antiviral agents (DAA) are a safe and highly effective treatment for hepatitis C virus (HCV) infection. However, the uptake of DAA treatment remains a challenge. This study aims to examine the reasons for DAA refusal among HCV patients cove...

Full description

Bibliographic Details
Main Authors: Li-Jen Chang, Han-Cheng Chang, Po-Yueh Chen, Chi-Yi Chen, Kun-Feng Tsai, Koh-Kok Yean, Hsin-Yi Yang, Tsung-Hsien Chen, Pao-Ta Yu, Chu-Kuang Chou, Sheng-Hsuan Chen
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Medicina
Subjects:
chronic hepatitis C
direct-acting antiviral therapy
Taiwan’s National Health Insurance
Online Access:https://www.mdpi.com/1648-9144/58/4/521

Internet

https://www.mdpi.com/1648-9144/58/4/521

Similar Items